Archive · 11 Nov 2025
Fredun Pharmaceuticals Sees Net Profit More Than Double in September Quarter
Fredun Pharmaceuticals, a company that makes medicines, had a really good three months from July to September.
They made twice as much profit as they did last year, earning 10 crore rupees!
Their total sales also went up by a lot, reaching 145 crore rupees.
The company is doing well because people are buying more of their medicines in India, and they are also selling more to other countries.
They even launched a new healthy food for pets that follows Jain principles, and it was so popular that they sold all of it!
To make even more products, they are building a bigger factory.
They also bought other pet-related companies to offer more things for pets, like food, technology, and services.
Fredun Pharmaceuticals' net profit doubled to ₹10 crore in the September quarter.
The company's income increased by 35% to ₹145 crore during the same period.
EBITDA saw a 60% rise, reaching ₹22 crore.
A new Jain functional food for pets, 'Snacky Jain,' sold out its initial batch via pre-orders.
Fredun Pharmaceuticals is expanding its manufacturing facility in Palghar and has acquired two pet-related companies.
- Who
- Fredun Pharmaceuticals
- What
- Reported net profit more than doubled to ₹10 crore and income jumped 35% to ₹145 crore in the September quarter.
- When
- September quarter (published November 11, 2025)
- Where
- India (domestic and international markets)
- Why
- Driven by strong performance in domestic formulations, rising institutional demand, steady exports, new product introductions, and successful pet product launches.
- Net Profit (September Quarter)
- ₹10 crore (doubled)
- Income (September Quarter)
- ₹145 crore (up 35%)
- EBITDA
- ₹22 crore (up 60%)
- Manufacturing Facility Location
- Palghar
- Stock Price Movement
- Up 5% at ₹1,710 on Tuesday